Cargando…
341. Evaluation of Antimicrobial Use and Prescribing Patterns During the COVID-19 Pandemic in Patients Receiving Tocilizumab
BACKGROUND: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infected patients experience systemic inflammation and respiratory distress, which appears to be associated with increased cytokine release. During the peak of coronavirus disease 2019 (COVID-19), tocilizumab was used to treat...
Autores principales: | Barsoum, Barbara, Chang, Kai-Ming, Mulvey, Nicole, Donaghy, Henry, Doan, Thien-Ly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643850/ http://dx.doi.org/10.1093/ofid/ofab466.542 |
Ejemplares similares
-
657. Evaluating Clinical Outcomes of Bacteremic Patients Treated with AmpC-Inducing Versus -Stable Agents
por: Barsoum, Barbara, et al.
Publicado: (2022) -
96. Assessing the Impact of the Meningitis/encephalitis Diagnostic Panel on Antimicrobial Stewardship
por: Garellek, Jonathan, et al.
Publicado: (2020) -
1431. Evaluation of Drug-induced Liver Injury in Patients Receiving Anti-tuberculosis Medications and Subsequent Management
por: Acosta, Carina, et al.
Publicado: (2022) -
205. Evaluating the Time to Oral Step-Down Therapy for Gram-Negative Bloodstream Infections Associated with a Genitourinary Source
por: Mulvey, Nicole, et al.
Publicado: (2021) -
103. Evaluating The Appropriateness of Vaccine Administration in Patients with Splenectomy
por: Barsoum, Barbara, et al.
Publicado: (2022)